Michelle Renee Griffin - 27 Mar 2023 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Director
Signature
/s/ Michelle Renee Griffin by Stacy L Taylor, Attorney-in-Fact
Issuer symbol
ADPT
Transactions as of
27 Mar 2023
Net transactions value
-$19,878
Form type
4
Filing time
29 Mar 2023, 17:01:50 UTC
Previous filing
16 Mar 2023
Next filing
31 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Sale $19,878 -2,341 -10% $8.49 20,627 27 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
F2 The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $8.41 to $8.55, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.